The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Triterpenoids as new promising anticancer drugs
Abstract
Triterpenoids are structurally diverse organic compounds, characterized by a basic backbone modified in multiple ways, allowing the formation of more than 20 000 naturally occurring triterpenoid varieties. Several triterpenoids, including ursolic and oleanolic acid, betulinic acid, celastrol, pristimerin, lupeol, and avicins possess antitumor and anti-inflammatory properties. To improve antitumor activity, some synthetic triterpenoid derivatives have been synthesized, including cyano-3,12-dioxooleana-1,9 (11)-dien-28-oic (CDDO), its methyl ester (CDDO-Me), and imidazolide (CDDO-Im) derivatives. Of these, CDDO, CDDO-Me, and betulinic acid have shown promising antitumor activities and are presently under evaluation in phase I studies. Triterpenoids are highly multifunctional and the antitumor activity of these compounds is measured by their ability to block nuclear factor-kappaB activation, induce apoptosis, inhibit signal transducer, and activate transcription and angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Prasad, S., Nigam, N., Kalra, N., & Shukla, Y. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20442 · Cited by 52
RetractedPharmacology of oleanolic acid and ursolic acid
Liu, J. (1995) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)90032-2 · Cited by 1,429
Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway
Zhang, D. D. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600971974 · Cited by 1,086
Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis
Li, W., Khor, T. O., Xu, C., Shen, G., Jeong, W.-S., Yu, S., & Kong, A.-N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.017 · Cited by 738
LAU, A., VILLENEUVE, N., SUN, Z., WONG, P., & ZHANG, D. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.09.003 · Cited by 645
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Liby, K. T., Yore, M. M., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2129 · Cited by 637
Hieronymus, H., Lamb, J., Ross, K. N., Peng, X. P., Clement, C., Rodina, A., Nieto, M., Du, J., Stegmaier, K., Raj, S. M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.005 · Cited by 624
Yang, H., Chen, D., Cui, Q. C., Yuan, X., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4529 · Cited by 586
Dinkova-Kostova, A. T., Liby, K. T., Stephenson, K. K., Holtzclaw, W. D., Gao, X., Suh, N., Williams, C., Risingsong, R., Honda, T., Gribble, G. W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500815102 · Cited by 569
Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
Luo, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.05.045 · Cited by 429
Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
Homma, S., Ishii, Y., Morishima, Y., Yamadori, T., Matsuno, Y., Haraguchi, N., Kikuchi, N., Satoh, H., Sakamoto, T., Hizawa, N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2822 · Cited by 418
Biosynthetic diversity in plant triterpene cyclization
Phillips, D. R., Rasbery, J. M., Bartel, B., & Matsuda, S. P. (2006) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2006.03.004 · Cited by 390
Sussan, T. E., Rangasamy, T., Blake, D. J., Malhotra, D., El-Haddad, H., Bedja, D., Yates, M. S., Kombairaju, P., Yamamoto, M., Liby, K. T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804333106 · Cited by 346
Sethi, G., Ahn, K. S., Pandey, M. K., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-10-050807 · Cited by 336
Lee, J.-H., Koo, T. H., Yoon, H., Jung, H. S., Jin, H. Z., Lee, K., Hong, Y.-S., & Lee, J. J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.014 · Cited by 308
Chintharlapalli, S., Papineni, S., Ramaiah, S. K., & Safe, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3735 · Cited by 297
Mechanism and its regulation of tumor-induced angiogenesis
Gupta, M. K. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i6.1144 · Cited by 294
Yates, M. S., Tauchi, M., Katsuoka, F., Flanders, K. C., Liby, K. T., Honda, T., Gribble, G. W., Johnson, D. A., Johnson, J. A., Burton, N. C., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0516 · Cited by 291
Liby, K., Hock, T., Yore, M. M., Suh, N., Place, A. E., Risingsong, R., Williams, C. R., Royce, D. B., Honda, T., Honda, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4539 · Cited by 283
Triterpenoid CDDO-Me Blocks the NF-κB Pathway by Direct Inhibition of IKKβ on Cys-179
Ahmad, R., Raina, D., Meyer, C., Kharbanda, S., & Kufe, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607160200 · Cited by 238
Reyes-Zurita, F. J., Rufino-Palomares, E. E., Lupiáñez, J. A., & Cascante, M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.07.033 · Cited by 197
Haridas, V., Higuchi, M., Jayatilake, G. S., Bailey, D., Mujoo, K., Blake, M. E., Arntzen, C. J., & Gutterman, J. U. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101619098 · Cited by 196
Yates, M. S., Kwak, M.-K., Egner, P. A., Groopman, J. D., Bodreddigari, S., Sutter, T. R., Baumgartner, K. J., Roebuck, B. D., Liby, K. T., Yore, M. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3823 · Cited by 191
Konopleva, M., Tsao, T., Ruvolo, P., Stiouf, I., Estrov, Z., Leysath, C. E., Zhao, S., Harris, D., Chang, S., Jackson, C. E., et al. (2002) · Blood · doi:10.1182/blood.v99.1.326 · Cited by 188
Hassane, D. C., Guzman, M. L., Corbett, C., Li, X., Abboud, R., Young, F., Liesveld, J. L., Carroll, M., & Jordan, C. T. (2008) · Blood · doi:10.1182/blood-2007-11-126003 · Cited by 185
The triterpenoid CDDO induces apoptosis in refractory CLL B cells
Pedersen, I. M., Kitada, S., Schimmer, A., Kim, Y., Zapata, J. M., Charboneau, L., Rassenti, L., Andreeff, M., Bennett, F., Sporn, M. B., et al. (2002) · Blood · doi:10.1182/blood-2002-04-1174 · Cited by 183
Betulinic acid induces apoptosis in human neuroblastoma cell lines
Schmidt, M. L., Kuzmanoff, K. L., Ling-Indeck, L., & Pezzuto, J. M. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00294-3 · Cited by 174
Zou, W., Liu, X., Yue, P., Zhou, Z., Sporn, M. B., Lotan, R., Khuri, F. R., & Sun, S.-Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1238 · Cited by 168
Cho, J.-M., Manandhar, S., Lee, H.-R., Park, H.-M., & Kwak, M.-K. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.10.022 · Cited by 166
Glycosidation of lupane-type triterpenoids as potent in vitro cytotoxic agents
Gauthier, C., Legault, J., Lebrun, M., Dufour, P., & Pichette, A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.05.075 · Cited by 161
Thimmulappa, R. K., Fuchs, R. J., Malhotra, D., Scollick, C., Traore, K., Bream, J. H., Trush, M. A., Liby, K. T., Sporn, M. B., Kensler, T. W., et al. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1745 · Cited by 155
Haridas, V., Arntzen, C. J., & Gutterman, J. U. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191363498 · Cited by 154
Place, A. E., Suh, N., Williams, C. R., Risingsong, R., Honda, T., Honda, Y., Gribble, G. W., Leesnitzer, L. M., Stimmel, J. B., Willson, T. M., et al. (2003) · PubMed · Cited by 149
Rzeski, W., Stepulak, A., Szymański, M., Sifringer, M., Kaczor, J., Wejksza, K., Zdzisińska, B., & Kandefer‐Szerszeń, M. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0090-1 · Cited by 147
Shishodia, S., Sethi, G., Konopleva, M. Y., Andreeff, M., & Aggarwal, B. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2044 · Cited by 147
Konopleva, M. Y., Tsao, T., Estrov, Z. E., Lee, R.-M., Wang, R., Jackson, C. E., McQueen, T. J., Monaco, G., Munsell, M. F., Belmont, J. W., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2402 · Cited by 146
Lapillonne, H., Konopleva, M. Y., Tsao, T., Gold, D. L., McQueen, T. J., Sutherland, R. L., Madden, T. L., & Andreeff, M. (2003) · PubMed · Cited by 144
Saleem, M., Kaur, S., Kweon, M., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi157 · Cited by 139
Ito, Y., Pandey, P., Sporn, M. B., Datta, R., Kharbanda, S., & Kufe, D. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1094 · Cited by 138
Saleem, M., Maddodi, N., Zaid, M. I. A., Khan, N., Hafeez, B. B., Asim, M., Suh, Y. K., Yun, J., Setaluri, V., & Mukhtar, H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4413 · Cited by 137
Betulinic acid-induced apoptosis in leukemia cells
Ehrhardt, H., Fulda, S., Führer, M., Debatin, K., & Jeremias, I. (2004) · Leukemia · doi:10.1038/sj.leu.2403406 · Cited by 135
Chauhan, D., Li, G., Podar, K., Hideshima, T., Shringarpure, R., Catley, L. P., Mitsiades, C. S., Munshi, N. C., Tai, Y., Suh, N., et al. (2003) · Blood · doi:10.1182/blood-2003-08-2873 · Cited by 135
Hyer, M. L., Croxton, R., Krajewska, M., Krajewski, S., Kress, C. L., Lü, M., Suh, N., Sporn, M. B., Cryns, V. L., Zapata, J. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3319 · Cited by 132
Saleem, M., Kweon, M., Yun, J., Adhami, V. M., Khan, N., Syed, D. N., & Mukhtar, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1965 · Cited by 131
Dietary agents for chemoprevention of prostate cancer
Syed, D. N., Suh, Y. K., Afaq, F., & Mukhtar, H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.050 · Cited by 129
Ito, Y., Pandey, P., Place, A., Sporn, M. B., Gribble, G. W., Honda, T., Kharbanda, S. M., & Kufe, D. W. (2000) · PubMed · Cited by 125
Mullauer, F. B., Kessler, J. H., & Medema, J. P. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0290-x · Cited by 124
Mujoo, K., Haridas, V., Hoffmann, J. J., Wächter, G. A., Hutter, L. K., Lu, Y., Blake, M. E., Jayatilake, G. S., Bailey, D. J., Mills, G. B., et al. (2001) · PubMed · Cited by 122
Reyes‐Zurita, F. J., Centelles, J. J., Lupiáñez, J. A., & Cascante, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.038 · Cited by 118
Thibeault, D., Gauthier, C., Legault, J., Bouchard, J., Dufour, P., & Pichette, A. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.06.033 · Cited by 117
Martín, R., Carvalho, J., Ibeas, E., Hernández, M., Ruíz-Gutiérrez, V., & Nieto, M. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4759 · Cited by 117
Yore, M. M., Liby, K. T., Honda, T., Gribble, G. W., & Sporn, M. B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0444 · Cited by 117
Liby, K. T., Voong, N., Williams, C. R., Risingsong, R., Royce, D. B., Honda, T., Gribble, G. W., Sporn, M. B., & Letterio, J. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0215 · Cited by 117
Shain, K. H., & Dalton, W. S. (2001) · PubMed · Cited by 117
Tiedemann, R. E., Schmidt, J. E., Keats, J. J., Shi, C.-X., Zhu, Y. X., Palmer, S. E., Mao, X., Schimmer, A. D., & Stewart, A. K. (2008) · Blood · doi:10.1182/blood-2008-09-179796 · Cited by 113
Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers
Hecht, S. S., Kassie, F., & Hatsukami, D. K. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2674 · Cited by 112
Ikeda, T., Sporn, M. B., Honda, T., Gribble, G. W., & Kufe, D. W. (2003) · PubMed · Cited by 111
A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase
Xu, Z.-X., Liang, J., Haridas, V., Gaikwad, A. S., Connolly, F. P., Mills, G. B., & Gutterman, J. U. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402207 · Cited by 110
Apoptosis Induction in HL-60 Cells and Inhibition of Topoisomerase II by Triterpene Celastrol
Nagase, M., Jinsei, O. T. O., SUGIYAMA, S., Yube, K., Takaishi, Y., & Sakato, N. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.1883 · Cited by 108
Samudio, I. J., Konopleva, M. Y., Hail, N., Shi, Y.-X., McQueen, T. J., Hsu, T., Evans, R. L., Honda, T., Gribble, G. W., Sporn, M. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507518200 · Cited by 105
Preclinical Studies of Celastrol and Acetyl Isogambogic Acid in Melanoma
Abbas, S., Bhoumik, A., Dahl, R. S., Vasile, S., Krajewski, S., Cosford, N. D. P., & Ronai, Z. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1536 · Cited by 101
Murtaza, I., Saleem, M., Adhami, V. M., Hafeez, B. B., & Mukhtar, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2917 · Cited by 97
Stadheim, T. A., Suh, N., Ganju, N., Sporn, M. B., & Eastman, A. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108974200 · Cited by 92
Kwon, H. J., Shim, J. S., Kim, J. H., Cho, H. Y., Yum, Y. N., Kim, S. H., & Yu, J. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01273.x · Cited by 92
Gao, X., Deeb, D., Jiang, H., Liu, Y., Dulchavsky, S. A., & Gautam, S. C. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9364-9 · Cited by 91
Haridas, V., Hanausek, M., Nishimura, G., Soehnge, H., Gaikwad, A. S., Naróg, M., Spears, E., Żółtaszek, R., Wałaszek, Z., & Gutterman, J. U. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18699 · Cited by 91
Ling, X., Konopleva, M. Y., Zeng, Z., Ruvolo, V. R., Stephens, L. C., Schober, W. D., McQueen, T. J., Dietrich, M. F., Madden, T. L., & Andreeff, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3629 · Cited by 90
Business Return in New Orleans: Decision Making Amid Post-Katrina Uncertainty
Lam, N., Pace, K., Campanella, R. G., LeSage, J. P., & Arenas, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006765 · Cited by 90
Rabi, T., Shukla, S., & Gupta, S. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20447 · Cited by 84
Chintharlapalli, S. R., Papineni, S., Konopleva, M. Y., Andreef, M., Samudio, I. J., & Safe, S. H. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011437 · Cited by 84
Ikeda, T., Nakata, Y., Kimura, F., Sato, K., Anderson, K. C., Motoyoshi, K., Sporn, M. B., & Kufe, D. W. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.39.3.1 · Cited by 80
Liby, K. T., Risingsong, R., Royce, D. B., Williams, C. R., Yore, M. M., Honda, T., Gribble, G. W., Lamph, W. W., Vannini, N., Sogno, I., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0040 · Cited by 77
Duan, Z., Ames, R. Y., Ryan, M. B., Hornicek, F. J., Mankin, H. J., & Seiden, M. V. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0785-8 · Cited by 75
Konopleva, M. Y., Zhang, W., Shi, Y.-X., McQueen, T. J., Tsao, T., Abdelrahim, M., Munsell, M. F., Johansen, M. J., Yu, D., Madden, T. L., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0350 · Cited by 70
Mix, K. S., Mengshol, J. A., Benbow, U., Vincenti, M. P., Sporn, M. B., & Brinckerhoff, C. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1096::aid-anr190>3.0.co;2-6 · Cited by 66
Liby, K. T., Honda, T., Williams, C. R., Risingsong, R., Royce, D. B., Suh, N., Dinkova‐Kostova, A. T., Stephenson, K. K., Talalay, P., Sundararajan, C., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0180 · Cited by 65
Deeb, D., Gao, X., Jiang, H., Dulchavsky, S. A., & Gautam, S. C. (2009) · The Prostate · doi:10.1002/pros.20937 · Cited by 63
Hyer, M. L., Shi, R., Krajewska, M., Meyer, C. J., Lebedeva, I. V., Fisher, P. B., & Reed, J. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5759 · Cited by 62
Zhang, L., Zhang, Y., Zhang, L., Yang, X., & Lv, Z.-C. (2009) · Cancer Investigation · doi:10.1080/07357900802210745 · Cited by 60
Samudio, I., Konopleva, M., Pelicano, H., Huang, P., Frolova, O., Bornmann, W., Ying, Y., Evans, R., Contractor, R., & Andreeff, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.018051 · Cited by 58
Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids
Sogno, I., Vannini, N., Lorusso, G., Cammarota, R., Noonan, D. M., Generoso, L., Sporn, M. B., & Albini, A. (2008) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-69297-3_19 · Cited by 58
Gopal, D. V. R., Narkar, A. A., Badrinath, Y., Mishra, K. P., & Joshi, D. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2004.06.015 · Cited by 58
Koschmieder, S., D’Alò, F., Radomska, H. S., Schöneich, C., Chang, J. S., Konopleva, M. Y., Kobayashi, S. S., Levantini, E., Suh, N., Ruscio, A. D., et al. (2007) · Blood · doi:10.1182/blood-2006-11-058941 · Cited by 57
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent
Vannini, N., Lorusso, G., Cammarota, R., Barberis, M. C. P., Noonan, D. M., Sporn, M. B., & Albini, A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0451 · Cited by 57
Liby, K. T., Yore, M. M., Roebuck, B. D., Baumgartner, K. J., Honda, T., Sundararajan, C., Yoshizawa, H., Gribble, G. W., Williams, C. R., Risingsong, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1123 · Cited by 56
Zou, W., Chen, S., Liu, X., Yue, P., Sporn, M. B., Khuri, F. R., & Sun, S. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.10.4763 · Cited by 55
Zhang, C., Li, B., Gaikwad, A. S., Haridas, V., Xu, Z., Gutterman, J. U., & Duvic, M. A. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.138 · Cited by 53
Samudio, I. J., Kurinna, S. M., Ruvolo, P. P., Korchin, B., Kantarjian, H. M., Beran, M., Dunner, K., Kondo, S., Andreeff, M., & Konopleva, M. Y. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0553 · Cited by 53
Brookes, P. S., Morse, K. M., Ray, D. M., Tompkins, A. J., Young, S. M., Hilchey, S. P., Salim, S., Konopleva, M. Y., Andreeff, M., Phipps, R. P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2678 · Cited by 51
Yue, P., Zhou, Z., Khuri, F. R., & Sun, S. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.5.2565 · Cited by 49
Ji, Y., Lee, H. J., Goodman, C., Uskoković, M. R., Liby, K. T., Sporn, M. B., & Suh, N. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0136 · Cited by 43
Deeb, D., Gao, X., Dulchavsky, S. A., & Gautam, S. C. (2008) · PubMed · Cited by 41
Gaikwad, A. S., Poblenz, A. T., Haridas, V., Zhang, C., Duvic, M. A., & Gutterman, J. U. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1704 · Cited by 39
Glycogen Synthase Kinase 3β Regulates Cell Death Induced by Synthetic Triterpenoids
Venè, R., Larghero, P., Arena, G., Sporn, M. B., Albini, A., & Tosetti, F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6362 · Cited by 38
Differentiation-inducing activity of lupane triterpenes on a mouse melanoma cell line
Hata, K., Mukaiyama, T., Tsujimura, N., Sato, Y., Kosaka, Y., Sakamoto, K., & Hori, K. (2006) · Cytotechnology · doi:10.1007/s10616-007-9069-0 · Cited by 35
PPARgamma-Active triterpenoid CDDO enhances ATRA-induced differentiation in APL
Tabe, Y., Konopleva, M. Y., Kondo, Y., Contractor, R., Tsao, T., Konoplev, S. N., Shi, Y., Ling, X., Watt, J. C., Tsutsumi‐Ishii, Y., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.12.4982 · Cited by 34
Favaloro, F. G., Honda, T., Honda, Y., Gribble, G. W., Suh, N., Risingsong, R., & Sporn, M. B. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025565f · Cited by 33
Liby, K. T., Black, C. C., Royce, D. B., Williams, C. R., Risingsong, R., Yore, M. M., Liu, X., Honda, T., Gribble, G. W., Lamph, W. W., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0023 · Cited by 33
To, C., Kulkarni, S., Pawson, T. J., Honda, T., Gribble, G. W., Sporn, M. B., Wrana, J. L., & Guglielmo, G. M. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704064200 · Cited by 31
Alabran, J. L., Cheuk, A., Liby, K. T., Sporn, M. B., Khan, J. I., Letterio, J. J., & Leskov, K. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.5.5713 · Cited by 31
Honda, T., Favaloro, F. G., Janosik, T., Honda, Y., Suh, N., Sporn, M. B., & Gribble, G. W. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b307491a · Cited by 31
Ray, D. M., Morse, K. M., Hilchey, S. P., Garcia, T. M., Felgar, R. E., Maggirwar, S. B., Phipps, R. P., & Bernstein, S. H. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.04.026 · Cited by 30
Haridas, V., Nishimura, G., Xu, Z.-X., Connolly, F., Hanausek, M., Wałaszek, Z., Żółtaszek, R., & Gutterman, J. U. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005578 · Cited by 30
High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide
Petronelli, A., Saulle, E., Pasquini, L., Petrucci, E., Mariani, G., Biffoni, M., Ferretti, G., Scambia, G., Panici, P. B., Greggi, S., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.03.018 · Cited by 28
Self-citationHughes, D. T., Martel, P. M., Kinlaw, W. B., & Eisenberg, B. L. (2008) · Cancer Investigation · doi:10.1080/07357900701522612 · Cited by 18
Chemical modulation of VLA integrin affinity in human breast cancer cells
Pec, M. K., Artwohl, M., Fernández, J. J., Souto, M. L., de la Rosa, D. Á., Giráldez, T., Valenzuela-Fernández, A., & Díaz‐González, F. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.01.015 · Cited by 16
Riccioni, R., Senese, M., Diverio, D., Riti, V., Mariani, G., Boe, A., Lo‐Coco, F., Foà, R., Peschle, C., Sporn, M. B., et al. (2008) · Leukemia Research · doi:10.1016/j.leukres.2007.12.008 · Cited by 7
Self-citationDezube, B. J., Kurzrock, R., Eder, J. P., Supko, J. G., Meyer, C. J., Camacho, L. H., Andreeff, M., Konopleva, M. Y., Lescale-Matys, L., & Hong, D. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.14101 · Cited by 7
Cited by
Pollier, J., & Goossens, A. (2012) · Phytochemistry · doi:10.1016/j.phytochem.2011.12.022 · Cited by 499
Liby, K. T., & Sporn, M. B. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004846 · Cited by 405
Plant volatiles: Production, function and pharmacology
Maffei, M. E., Gertsch, J., & Appendino, G. (2011) · Natural Product Reports · doi:10.1039/c1np00021g · Cited by 369
Terpenoids as potential chemopreventive and therapeutic agents in liver cancer
Thoppil, R. J. (2011) · World Journal of Hepatology · doi:10.4254/wjh.v3.i9.228 · Cited by 353
Terpenoids: natural products for cancer therapy
Huang, M., Lu, J.-J., Huang, M.-Q., Bao, J.-L., Chen, X.-P., & Wang, Y.-T. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.727395 · Cited by 333
Metadata
- Authors
- Petronelli, A., Pannitteri, G., & Testa, U.
- Venue
- Anti-Cancer Drugs
- Published
- 2009-11
- Volume
- 20
- Issue
- 10
- Pages
- 880-892
- ISSN
- 0959-4973 (ISSN-L)
- OpenAlex
- W1977773503
- Cited by
- 381
- References
- 108
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.